Clinical Trial Search

Primary: Change From Baseline in Glycosylated Haemoglobin (HbA1c) (Percentage [%]) — -0.57; -0.54 Percentage of HbA1c — p=0.5102

Primary: Number of Subjects Screening Positive for Blood Around the Abdominal Organs (Hemoperitoneum) After Trauma, as Assessed by Focused Assessment With Sonography for Trauma…

Primary: Best-Corrected Visual Acuity of Amblyopic Eye — 1.77; 0.85 Lines of visual acuity improvement

Primary: Dose Response of Intravenous Oxytocin on Sustained Heat Pain — 3.1; 2.9; 3.1; 2.9 units on a scale — p=<0.05

Primary: Number of Participants With Detection of Hematoma Stratified by CT Positive and CT Negative Status — 158; 22; 126; 81 Participants

Primary: Progression of Subclinical Atherosclerosis — 0.013; 0.011 mm per year — p=0.31

Primary: Non-displaceable Tracer Binding Potentials — 2.93; 2.91; 1.50; 1.50 ratio

Primary: Overall Response Rate (ORR) as Determined by Local Investigator — 32.1 Percentage of participants

Primary: Multnomah Community Ability Scale - Participant Interview Based — 65.45; 67.83; 64.66 Total Score

Primary: Participants Complete Response — 9 Participants

Primary: Phase I: Number of Patients With Dose Limiting Toxicity (DLT(s)) During First Treatment Cycle — 0; 0; 0; 1 Participants

Primary: Dorsomedial Prefrontal Cortex Activation — 0.16; 1.35; 0.36 score in arbitrary units — p=0.80

Primary: Postprandial Glucose Control — 36.18; 45.22 percentage of time in range (TIR)

Primary: Participants Initiating Pre-exposure Prophylaxis During Pregnancy — 1089 Participants

Primary: Index of Multisensory Processing (IMP) — 31.4; 49.0; 35.6; 18.8 percentage of time